GNPTAB

N-acetylglucosamine-1-phosphate transferase alpha and beta subunits
OMIM: 607840, Gene2Phenotype

15 panels

Panel Reviews Mode of inheritance Details
15 panels
Green GNPTAB in Mucopolysaccharideosis, Gaucher, Fabry

Level 3: Lysosomal storage disorders
Level 2: Metabolic disorders
Version 1.5

review BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Illumina TruGenome Clinical Sequencing Services
Phenotypes
  • Mucolipidosis, Type II
  • Mucolipidosis, Type III Alpha/Beta
  • Mucolipidosis II alpha/beta
  • Mucolipidosis III alpha/beta
Red GNPTAB in Hyperammonaemia

Level 3: Urea Cycle disorders
Level 2: Metabolic disorders
Version 1.22

review Not set
Sources
  • Emory Genetics Laboratory
Green GNPTAB in Fetal hydrops

Level 3: Fetal disorders
Level 2: Dysmorphic and congenital abnormality syndromes
Version 1.108

review BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
Phenotypes
  • Mucolipidosis, Type II
  • Mucolipidosis, Type III Alpha/Beta
  • Mucolipidosis II alpha/beta
  • Mucolipidosis III alpha/beta
  • I-cell disease
Green GNPTAB in Lysosomal storage disorder


Level 2: Metabolic
Version 3.11
Latest signed off version: v3.10 (12 Aug 2026)

review BIALLELIC, autosomal or pseudoautosomal
Sources
  • NHS GMS
  • Wessex and West Midlands GLH
  • Expert Review Green
  • North London GLH
Phenotypes
  • Mucolipidosis II alpha/beta OMIM:252500
  • mucolipidosis type II MONDO:0009650
  • Mucolipidosis III alpha/beta OMIM:252600
  • mucolipidosis type III MONDO:0018931
Green GNPTAB in Skeletal dysplasia


Level 2: Musculoskeletal
Version 10.5
Latest signed off version: v10.0 (12 Aug 2026)

Component of the following Super Panels:

  • Paediatric disorders
  • review BIALLELIC, autosomal or pseudoautosomal
    Sources
    • NHS GMS
    • Expert Review Green
    • Radboud University Medical Center, Nijmegen
    • Illumina TruGenome Clinical Sequencing Services
    • Emory Genetics Laboratory
    • Expert list
    • UKGTN
    Phenotypes
    • Mucolipidosis III alpha/beta 252600
    • Mucolipidosis II alpha/beta 252500
    Green GNPTAB in Undiagnosed metabolic disorders

    Level 3: Specific metabolic abnormalities
    Level 2: Metabolic disorders
    Version 1.645

    review BIALLELIC, autosomal or pseudoautosomal
    Sources
    • Expert Review Green
    • Literature
    Phenotypes
    • Mucolipidosis II, I-cell disease (Other lysosomal disorders)
    • Mucolipidosis, Type II
    • Mucolipidosis, Type III Alpha/Beta
    • Mucolipidosis II alpha/beta
    • Mucolipidosis III alpha/beta
    Green GNPTAB in Likely inborn error of metabolism


    Level 2: Metabolic
    Version 9.30
    Latest signed off version: v9.29 (12 Aug 2026)

    Component of the following Super Panels:

  • Hypotonic infant
  • Leukodystrophy, childhood onset
  • Paediatric disorders
  • Unexplained death in infancy and sudden unexplained death in childhood
  • review BIALLELIC, autosomal or pseudoautosomal
    Sources
    • London North GLH
    • NHS GMS
    • Expert Review Green
    Phenotypes
    • Mucolipidosis, Type II
    • Mucolipidosis, Type III Alpha/Beta
    • Mucolipidosis III alpha/beta
    • Mucolipidosis II, I-cell disease (Other lysosomal disorders)
    • Mucolipidosis II alpha/beta
    Green GNPTAB in Fetal anomalies


    Level 2: Fetal (including NIPD)
    Version 8.4
    Latest signed off version: v8.0 (12 Aug 2026)

    review BIALLELIC, autosomal or pseudoautosomal
    Sources
    • PAGE DD-Gene2Phenotype
    • Expert Review Green
    Phenotypes
    • MUCOLIPIDOSIS TYPE II
    • MUCOLIPIDOSIS TYPE III COMPLEMENTATION GROUP A
    Green GNPTAB in Rare syndromic craniosynostosis or isolated multisuture synostosis


    Level 2: Musculoskeletal
    Version 7.1
    Latest signed off version: v7.0 (12 Aug 2026)

    review BIALLELIC, autosomal or pseudoautosomal
    Sources
    • NHS GMS
    • Expert Review Green
    • Expert list
    Phenotypes
    • 252500
    • Mucolipidosis II alpha/beta(I cell disease) 252500
    Red GNPTAB in Osteogenesis imperfecta


    Level 2: Musculoskeletal
    Version 6.8
    Latest signed off version: v6.7 (12 Aug 2026)

    review BIALLELIC, autosomal or pseudoautosomal
    Sources
    • Expert Review Red
    • Expert Review
    Phenotypes
    • I-cell disease (Mucolipidosis Type II)
    Green GNPTAB in DDG2P


    Version 8.1
    Latest signed off version: v8.0 (12 Aug 2026)

    Component of the following Super Panels:

  • Paediatric disorders
  • review BIALLELIC, autosomal or pseudoautosomal
    Sources
    • DD-Gene2Phenotype
    • Expert Review Green
    Phenotypes
    • MUCOLIPIDOSIS TYPE II 252500
    • MUCOLIPIDOSIS TYPE III COMPLEMENTATION GROUP A 252600
    Green GNPTAB in Intellectual disability


    Level 2: Developmental disorders
    Version 11.17
    Latest signed off version: v11.0 (12 Aug 2026)

    Component of the following Super Panels:

  • Hypotonic infant
  • Leukodystrophy, childhood onset
  • Paediatric disorders
  • review BIALLELIC, autosomal or pseudoautosomal
    Sources
    • Victorian Clinical Genetics Services
    • Expert Review Green
    Phenotypes
    • MUCOLIPIDOSIS TYPE II (MLII)
    Red GNPTAB in Retinal disorders


    Level 2: Ophthalmology
    Version 9.19
    Latest signed off version: v9.14 (12 Aug 2026)

    review Not set
    Sources
    • NHS GMS
    Red GNPTAB in Dystonia, chorea or related movement disorder, childhood onset


    Level 2: Neurology
    Version 8.14
    Latest signed off version: v8.13 (12 Aug 2026)

    review Not set
    Sources
    • Expert Review Red
    • London North GLH
    Green GNPTAB in Mucolipidosis II and III Alpha or Beta


    Level 2: Metabolic
    Version 1.5
    Latest signed off version: v1.4 (12 Aug 2026)

    review BIALLELIC, autosomal or pseudoautosomal
    Sources
    • NHS GMS
    • Expert Review Green
    Phenotypes
    • Mucolipidosis II alpha/beta, OMIM:252500
    • Mucolipidosis III alpha/beta, OMIM:252600
    • GNPTAB-mucolipidosis, MONDO:0100122